Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001104659-25-030601
Filing Date
2025-04-01
Accepted
2025-04-01 16:37:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12G/A tm2511075d2_8a12ga.htm 8-A12G/A 27818
  Complete submission text file 0001104659-25-030601.txt   29151
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12G/A | Act: 34 | File No.: 000-12957 | Film No.: 25800341
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)